Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-6.4
Price to sales ratio
5.73

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3316
MYGN
Myriad Genetics, Inc. - Common Stock
3.18 USD+1.92%-1.24%-40.34%-61.55%304.17 M USD
3329
BDSX
Biodesix, Inc. - Common Stock
28.48 USD-6.93%+17.44%+34.09%+127.66%300.50 M USD
3555
STIM
Neuronetics, Inc. - Common Stock
2.96 USD-1.33%-5.43%+59.14%-14.45%225.54 M USD
3681
XGN
Exagen Inc. - Common Stock
7.52 USD-1.96%-3.09%+68.61%-22.95%182.17 M USD

Frequently asked questions about Standard BioTools Inc. Common Stock

What is the Standard BioTools Inc. Common Stock stock price today?

The current price of Standard BioTools Inc. Common Stock (LAB) is 0.65. Over the past 24 hours, the stock has changed by 0.00%. Follow the LAB chart for real-time price dynamics.

What is the stock ticker of Standard BioTools Inc. Common Stock?

Standard BioTools Inc. Common Stock trades under the ticker LAB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Standard BioTools Inc. Common Stock stock going up?

LAB has changed by +3.17% over the last week, -16.67% over the last month, and -50.38% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Standard BioTools Inc. Common Stock?

Standard BioTools Inc. Common Stock currently has a market capitalization of 255.18 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Standard BioTools Inc. Common Stock earnings last quarter?

Last quarter, Standard BioTools Inc. Common Stock reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Standard BioTools Inc. Common Stock revenue for the last quarter?

Standard BioTools Inc. Common Stock reported quarterly revenue of 20.1 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Standard BioTools Inc. Common Stock net income for the last quarter?

Standard BioTools Inc. Common Stock reported net income of -26.76 M for the last quarter. The previous quarter showed 127.07 M, which means net income changed by -121.06%.

How many employees does Standard BioTools Inc. Common Stock have?

As of the latest available data, Standard BioTools Inc. Common Stock has 389 employees. Workforce size can provide additional context about the company's scale and operations.

What is Standard BioTools Inc. Common Stock EBITDA?

Standard BioTools Inc. Common Stock EBITDA is -25.3 M, and its EBITDA margin is -125.82%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Standard BioTools Inc. Common Stock stock?

You can buy Standard BioTools Inc. Common Stock (LAB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Standard BioTools Inc. Common Stock stock?

Investing in Standard BioTools Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LAB chart and related analysis on metatrader.com as part of your research.

Standard BioTools Inc. - Common Stock

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.

News